Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-18-018332

See Remarks acquired 4,643 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ZDRAVESKI ZORAN See Remarks 2018-06-25 Conversion +4,643 140,092 D
Derivatives
ZDRAVESKI ZORAN See Remarks 2018-06-25 Conversion · Series C Preferred Stock −12,000 0 D
Loading xslF345X03/doc4.xml…